![Matthew Hawryluk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 81 737 $ al 31/05/2026
Matthew J.
Hawryluk is currently Independent Director at Axe Compute, Inc. since 2022, Director at Ourotech, Inc., and Chief Business Officer at Prime Medicine, Inc. starting in 2025.
Formerly, Dr. Hawryluk was Vice President-Corporate & Business Development at Foundation Medicine, Inc. and Chief Business Officer & Executive Vice President at Gritstone bio, Inc. from 2015 to 2024.
Education includes undergraduate studies at the University of Notre Dame, an MBA from Tepper School of Business, and a doctorate from the University of Pittsburgh School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AXE COMPUTE INC. 0,35 % | 20/04/2026 | 11.727 ( 0,35 % ) | 81 737 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PRECISION THERAPEUTICS INC | Director/Miembro de la Junta | 29/11/2022 |
| PRIME MEDICINE, INC. | Corporate Officer/Principal | 03/11/2025 |
Ourotech, Inc.
 Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 31/12/2024 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predictive Oncology, Inc.
 Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Ourotech, Inc.
Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
